Insider Trading & Ownership of Paul L. Berns

Location
Westminster, CO
Summary
The estimated net worth of Paul L. Berns is at least $13.7M dollars as of November 13, 2025. Paul L. Berns is the Title: Chief Executive Officer and Chairman of the Board, Director of Neumora Therapeutics, Inc. and owns shares of Neumora Therapeutics, Inc. (NMRA) stock worth about $12.8M. Paul L. Berns is the Director of Jazz Pharmaceuticals plc and owns shares of Jazz Pharmaceuticals plc (JAZZ) stock worth about $988K.
Signature
/s/ Matthew Lang, Attorney-in-Fact for Paul L. Berns
All Insider Reports
All Insider Reports

Notify me when Paul L. Berns files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Paul L. Berns

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NMRA Neumora Therapeutics, Inc. Title: Chief Executive Officer and Chairman of the Board, Director $12.8M -$23.5K -0.18% May 28, 2025
JAZZ Jazz Pharmaceuticals plc Director $988K Aug 5, 2021
MTSR Metsera, Inc. Director $0 Nov 13, 2025
EQRX EQRx, Inc. Director Nov 9, 2023
UBX Unity Biotechnology, Inc. Director Jun 21, 2024

Insider Transactions Reported by Paul L. Berns:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.